Compare IDEXX Laboratories, Inc. (IDXX) vs TotalEnergies SE (TTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs TotalEnergies SE — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while TotalEnergies SE trades at $86.11 (market cap $191.82B). The key difference: TotalEnergies SE is far larger — about 4.7× IDEXX Laboratories, Inc.'s market cap, and TotalEnergies SE pays a 4.93% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and TotalEnergies SE for 90 Days on average.
| IDXX | TTE | |
|---|---|---|
Market Cap | $40.43B | $191.82B |
Volume | 692,164 | 3,311,339 |
Sector | Health | Energy |
52-Week High | $766.68 | $93.60 |
52-Week Low | $504.70 | $57.39 |
Typical Hold Time | 46 Days | 90 Days |
Enterprise Value | $41.32B | $222.81B |
Dividend Yield | — | 4.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% on the day, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $4.27 exceeding the $3.94 estimate. Revenue grew to $4.3 billion in 2025, and net income margin expanded to 25.03%. Recent acquisitions like CoVetAI aim to enhance veterinary workflow intelligence.
The outlook remains positive given robust profitability and analyst consensus, but risks include foreign exchange headwinds and competitive pressures. With a consensus price target of $665, representing ~30% upside, the stock offers growth potential for investors comfortable with its premium valuation multiples.
TotalEnergies (TTE) trades at $86.02, up 2.13% for the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported mixed quarterly earnings, with Q1 and Q2 2026 beats but a Q4 2025 miss. Revenue declined to $182.34B in 2025, though net income margin held at 9.08%. Recent news highlights a $10B investment in Argentina and a strategic focus on boosting cash flow and dividends through 2030.
TTE offers value with a P/E of 10.77 and strong cash generation, supported by a 55.88% analyst buy rating and a $95.33 consensus price target. Risks include declining revenue trends, geopolitical exposure, and energy price volatility. The stock presents a balanced opportunity for income and growth investors, with upside potential if execution on expansion plans materializes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About TotalEnergies SE
TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.5 million barrels of liquids and 7.2 billion cubic feet of natural gas per day. At year-end 2020, reserves stood at 12.1 billion barrels of oil equivalent, 45% of which are liquids. During 2021, it had LNG sales of 42 Mt. The company owns interests in refineries with capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. It also holds a 19% interest in Russian oil company Novatek. At year-end, its gross installed renewable power generation capacity was 10.3 GW.
Read more on TTE →
